These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3495461)

  • 1. Langerhans cells in epidermodysplasia verruciformis.
    Haftek M; Jabłońska S; Szymańczyk J; Jarzabek-Chorzelska M
    Dermatologica; 1987; 174(4):173-9. PubMed ID: 3495461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigen presentation and T-cell activation in epidermodysplasia verruciformis.
    Cooper KD; Androphy EJ; Lowy D; Katz SI
    J Invest Dermatol; 1990 Jun; 94(6):769-76. PubMed ID: 2162366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermodysplasia verruciformis: Langerhans cells, immunologic effect of retinoid treatment and cytogenetics.
    van Voorst Vader PC; de Jong MC; Blanken R; Kallenberg CG; Vermey A; Scheres JM
    Arch Dermatol Res; 1987; 279(6):366-73. PubMed ID: 3499869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expressions of CD1a and CD83 of Langerhans cells in the local lesions of epidermodysplasia verruciformis patients].
    Liang S; Liu YH; Zuo YG; Wang BX; Fang K
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Feb; 31(1):17-9. PubMed ID: 19317050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of HLA-DR and OKT6 antigens on keratinocytes and dendritic cells in pemphigus.
    Picut C; Meunier J; Lee C; Lewis R
    Arch Dermatol Res; 1987; 279(8):516-20. PubMed ID: 2449139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermodysplasia verruciformis-like eruption complicating human immunodeficiency virus infection.
    Barzegar C; Paul C; Saiag P; Cassenot P; Bachelez H; Autran B; Gorochov G; Petit A; Dubertret L
    Br J Dermatol; 1998 Jul; 139(1):122-7. PubMed ID: 9764163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermodysplasia verruciformis accompanied by familial large granular lymphocytosis and a decrease in T lymphocytes.
    Aoyama H; Seki S; Abo T; Usuba Y; Tomita Y; Tagami H
    Acta Derm Venereol; 1993 Feb; 73(1):52-4. PubMed ID: 8095753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonspecific cell-mediated immunity in patients with epidermodysplasia verruciformis.
    Pereira de Oliveira WR; Carrasco S; Neto CF; Rady P; Tyring SK
    J Dermatol; 2003 Mar; 30(3):203-9. PubMed ID: 12692356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of HLA-DR molecules by keratinocytes, and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaques.
    Gottlieb AB; Lifshitz B; Fu SM; Staiano-Coico L; Wang CY; Carter DM
    J Exp Med; 1986 Oct; 164(4):1013-28. PubMed ID: 2428913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transduction of the E6 and E7 genes of epidermodysplasia-verruciformis-associated human papillomaviruses alters human keratinocyte growth and differentiation in organotypic cultures.
    Boxman IL; Mulder LH; Noya F; de Waard V; Gibbs S; Broker TR; ten Kate F; Chow LT; ter Schegget J
    J Invest Dermatol; 2001 Dec; 117(6):1397-404. PubMed ID: 11886500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermodysplasia verruciformis.
    Jablonska S; Orth G
    Clin Dermatol; 1985; 3(4):83-96. PubMed ID: 2850863
    [No Abstract]   [Full Text] [Related]  

  • 12. [Successful symptomatic treatment of epidermodysplasia verruciformis with imiquimod 5% cream].
    Heratizadeh A; Völker B; Kupsch E; Wichmann K; Kapp A; Werfel T
    Hautarzt; 2010 Dec; 61(12):1052-5. PubMed ID: 20824263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TMC8 mutation in a Turkish family with epidermodysplasia verruciformis including laryngeal papilloma and recurrent skin carcinoma.
    Esenboga S; Cagdas D; Alkanat NE; Güler Tezel G; Ersoy Evans S; Boztug K; Tezcan I
    J Cosmet Dermatol; 2022 May; 21(5):2263-2267. PubMed ID: 34416085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquired epidermodysplasia verruciformis in an HIV-positive patient.
    Lau C; Acharya S; Arumainayagam JT; Kasparis C; Dhesi I
    Int J STD AIDS; 2016 Oct; 27(11):1023-5. PubMed ID: 26516132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermodysplasia verruciformis: an unusual malignant transformation.
    Agrawal PG; Mahajan SA; Khopkar US; Kharkar VD
    Indian J Dermatol Venereol Leprol; 2013; 79(1):97-9. PubMed ID: 23254737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction in CD1 positive epidermal Langerhans cell numbers in leprosy lesions following epicutaneous application of 2:4 dinitrochlorobenzene.
    Narayanan RB; Natarajan M; Bagga AK; Katoch K
    Indian J Lepr; 1993; 65(4):423-7. PubMed ID: 8182289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired epidermodysplasia verruciformis.
    Rogers HD; Macgregor JL; Nord KM; Tyring S; Rady P; Engler DE; Grossman ME
    J Am Acad Dermatol; 2009 Feb; 60(2):315-20. PubMed ID: 19150275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermodysplasia verruciformis occurring in a patient with human immunodeficiency virus: a case report.
    Hultgren TL; Srinivasan SK; DiMaio DJ
    Cutis; 2007 Apr; 79(4):307-11. PubMed ID: 17500379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical aspects of epidermodysplasia verruciformis.
    de Oliveira WR; Festa Neto C; Rady PL; Tyring SK
    J Eur Acad Dermatol Venereol; 2003 Jul; 17(4):394-8. PubMed ID: 12834447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [HPV-20-induced epidermodysplasia verruciformis].
    Wätzig V; Jablonská S
    Hautarzt; 1987 Sep; 38(9):521-4. PubMed ID: 2826363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.